The NASH pathogenesis involves multiple drivers associated with aberrant fat and carbohydrate handling, including formation of fatty acid-derived lipotoxic species, accumulating mitochondrial oxidative stress, reduced insulin sensitivity and imbalanced immune responses. The gene discussed is INS; the disease is metabolic dysfunction-associated steatohepatitis.